By Conjoint Professor Dedee Frances Murrell

Book Chapters

Lara-Corrales I; Bruckner AL; Salas Alanis JC; Mellerio JE; Pallison F; Murrell DF, 2015, 'Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 667 - 685, http://dx.doi.org/10.1007/978-3-662-45698-9_71

Tan JCK; Murrell DF; Coroneo M, 2015, 'Ocular Involvement in Autoimmune Blistering Skin Diseases', in Blistering Diseases Clinical Features Pathogenesis Treatment, pp. 449 - 455, http://dx.doi.org/10.1007/978-3-662-45698-9_45

Mendoza CG; Black MM; Murrell DF, 2015, 'Pemphigoid Gestationis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 343 - 350, http://dx.doi.org/10.1007/978-3-662-45698-9_32

Kim J; Kim J; Hertl M; Korman NJ; Murrell DF, 2015, 'Pemphigus Vulgaris', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 283 - 288, http://dx.doi.org/10.1007/978-3-662-45698-9_24

Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN, 2015, 'Prevention and Treatment of Infections in Patients with Autoimmune Blistering Disease', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 611 - 615, http://dx.doi.org/10.1007/978-3-662-45698-9_65

Cianchini G; Paradisi A; Murrell DF, 2015, 'Quality of Life in Autoimmune Blistering Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 623 - 631, http://dx.doi.org/10.1007/978-3-662-45698-9_67

Kho YC; Daniel BS; Murrell DF; Joly P, 2015, 'Rituximab and Its Use in Autoimmune Bullous Disorders', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 523 - 529, http://dx.doi.org/10.1007/978-3-662-45698-9_53

Tan JCK; Coroneo M; Martinez A; Tosti A; Murrell DF, 2015, 'Special Issues in Epidermolysis Bullosa: Eyes, Hair, Nails, Teeth and Pregnancy', in Blistering Diseases Clinical Features Pathogenesis Treatment, pp. 695 - 709, http://dx.doi.org/10.1007/978-3-662-45698-9_73

Bruckner AL; Pope E; Mellerio JE; Bodemer C; Colomb V; Diem A; Murrell DF, 2015, 'Supportive Care: Bathing, Wound Care, Nutrition, Pain and Itch Management, Psychosocial Support, Palliation', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 653 - 666, http://dx.doi.org/10.1007/978-3-662-45698-9_70

Lazo-Dizon JPH; Murrell DF, 2015, 'Tetracyclines and Their Use in Autoimmune Bullous Diseases and Epidermolysis Bullosa', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 501 - 505, http://dx.doi.org/10.1007/978-3-662-45698-9_50

Brennan FP; Lim CHL; Murrell DF, 2015, 'The Pathogenesis, Assessment and Management of Pruritus in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 643 - 649, http://dx.doi.org/10.1007/978-3-662-45698-9_69

Kim J; Daniel BS; Werth VP; Joly P; Murrell DF, 2015, 'The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 533 - 541, http://dx.doi.org/10.1007/978-3-662-45698-9_54

Micheletti RG; Murrell DF; Werth VP, 2015, 'Treatment and Prevention of Glucocorticoid-Induced Osteoporosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 593 - 603, http://dx.doi.org/10.1007/978-3-662-45698-9_63

George R; Cardones ARG; Murrell DF; Hall RP, 2015, 'Treatment of Dermatitis Herpetiformis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 573 - 578, http://dx.doi.org/10.1007/978-3-662-45698-9_60

Kim M; Lucky AW; Azizkhan RG; Bernardis C; Murrell DF, 2015, 'Treatment of EB Complications: Esophageal Strictures, Pseudosyndactyly, Urethral and Meatal Stenosis, and Laryngeal Stenosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 687 - 694, http://dx.doi.org/10.1007/978-3-662-45698-9_72

Chee SN; Murrell DF, 2015, 'Using Intravenous Immunoglobulins in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 515 - 521, http://dx.doi.org/10.1007/978-3-662-45698-9_52

Martin LK; Sperber BR; Murrell DF; Werth VP, 2014, 'Pemphigus', in Evidence Based Dermatology Third Edition, pp. 552 - 560, http://dx.doi.org/10.1002/9781118357606.ch65

Intong LRA; Murrell DF, 2011, 'Erythema Multiforme, Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis', in Harper S Textbook of Pediatric Dermatology Volume 1 Thrid Edition, pp. 78.1 - 78.8, http://dx.doi.org/10.1002/9781444345384.ch78

Venugopal SS; Murrell DF, 2011, 'Diagnosis and Prevention of Bullous Diseases', in Preventive Dermatology in Infectious Diseases, Springer Nature, pp. 53 - 73, http://dx.doi.org/10.1007/978-0-85729-847-8_6

Leonard T; Delamere F; Murrell D, 2009, 'The Cochrane Skin Group', in Evidence Based Dermatology Second Edition, pp. 20 - 25, http://dx.doi.org/10.1002/9781444300161.ch4

Khumalo NP; Kirtschig G; Middleton PM; Hollis S; Wojnarowska F; Murrell DF, 2003, 'Interventions for bullous pemphigoid', in The Cochrane Library, John Wiley & Sons, UK

Kirtschig G; Murrell DF; Wojnarowska F; Khumalo NP, 2003, 'Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita (Cochrane Review)', in Cochrane Database of Systematic Reviews, John Wiley & Sons Ltd, England

Leonard T; Delamere F; Murrell DF, 2003, 'The Cochrane Skin Group', in Williams H; Bigby M; Diepgen T; Herxheimer A; Naldi L; Rzany B (ed.), Evidence-based Dermatology, BMJ Publishing Group, London, UK, pp. 24 - 32

Journal articles

Amsalu A; Haidari H; Mirco B; Rudolph-Stringer V; Walter S; Antipov A; Murrell DF; Kopecki Z, 2026, 'Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients', Orphanet Journal of Rare Diseases, 21, http://dx.doi.org/10.1186/s13023-026-04295-5

Akbarialiabad H; Safaee E; Letafati M; Gong J; Leachman SA; Grada A; Pasdar A; Janatifar M; Shakil F; Bunick CG; Murrell DF; Tarbox M; West C; Haghighi A, 2026, 'Generative AI empowered digital twins for advancing precision medicine', Discover Artificial Intelligence, 6, http://dx.doi.org/10.1007/s44163-026-01034-4

Stein Gold L; Armstrong AW; Soung J; Vender RB; González Cantero Á; Hoffmann M; Guenthner ST; Hong HCH; Murrell DF; Song EJ; Kircik L; Augustin M; Sauder M; Gerdes S; Reyes-Servin O; Edem BE; Campbell J; Cresswell K; Kephart L; Li S; Yang YW; Bissonnette R, 2026, 'Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials', British Journal of Dermatology, 195, pp. 600, http://dx.doi.org/10.1093/bjd/ljag264

Joly P; Murrell DF; Aoyama Y; Caux F; De D; Flouri M; Goebeler M; Ji C; Kiritsi D; Pan M; Patsatsi A; Schmidt E; Vassileva S; Vandersarren L; Stoykov I; Verheesen P; Werth VP; Hall RP; Murrell D; Kern J; Vassileva S; Kantardjiev V; Gospodinov D; Li H; Li W; Pan M; Chen Y; Ji C; Zhang S; Fang S; Perrot J-L; Templier I; Caux F; Joly P; Buchukuri I; Galdava G; Kobakhidze J; Hertl M; Kiritsi D; Pinter A; Hahn M; Goebeler M; Gerdes S; Günther C; Chasapi V; Ioannides D; Papadavid E; Papakonstantis M; Patsatsi A; Stratigos A; Bata-Csörgő Z; Remenyik É; De D; Shah B; Mukhi J; Madan A; De Simone C; Didona B; Parodi A; Caproni M; Micali G; Cinotti E; Tanaka A; Aoyama Y; Osada A; Ujiie H; Tsuruta D; Ishii N; Kambayashi Y; Reich A; Placzek K; Szepietowski J; Zebrowska A; Baican AL; Solovăstru LG; Khotko A; Skrek S; Temnikov V; Kokhan M; Sokolovskiy E; Gajinov Z; Tiodorovic D; Barbarin JF; Galy J-MM; Bueno DM; Kutlubay Z; Polion N; Reznichenko N; Lytvynenko B; Chaplyk-Chyzho I; Aleksandruk O; Chua SL; Shipley DV; Carrasco D; Graham L; Colton A; Sinha A; Mangold A; Marinkovich MP; Hall R; Hsu S; Hurley M; Waibel J, 2026, 'Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial', British Journal of Dermatology, pp. ljag199, http://dx.doi.org/10.1093/bjd/ljag199

Cascio Ingurgio R; Alfano A; Syed A; Gargiulo L; Narcisi A; Costanzo A; Murrell DF, 2026, 'Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study', Journal of Dermatology, 53, pp. 1353 - 1357, http://dx.doi.org/10.1111/1346-8138.70389

Has C; di Calabria VR; Caproni M; Didona B; Fischer J; Gostynski A; Javid AH; Hannula-Jouppi K; Hofmann J; Maione V; Salavastru C; Zanghi S; Bauer JW; Giehl K; Gruber R; Harjama L; Marinovic B; Moosbrugger-Martinz V; Medvecz M; Müller S; Murrell D; Navarini A; Morice-Picard F; Schmuth M; Severino-Freire M; Tournier C; Dodiuk-Gad R; Bodemer C; Mazereeuw-Hautier J, 2026, 'Consensus Recommendations for Management of Darier Disease: A Practical Approach', Dermatology and Therapy, 16, pp. 4769 - 4800, http://dx.doi.org/10.1007/s13555-026-01838-3

Murrell DF; Boucher D; Daneshpazhooh M; Mahmoudi H; Kianfar N; Dasdar S; Yale M; Wilson A; Bilgic A; Uzun S; Chandran NS; Patsatsi A; Drenovska K; Vassileva S; Caux F; Culton DA; Hertl M; Lim YL; Marinović B; Marzano AV; Payne AS; Schmidt E; Sprecher E; Van Beek N; Yamagami J; Antiga E; Bagci IS; Borradori L; Caproni M; Corrà A; De D; Dunn P; Feliciani C; Fivenson DP; Günther C; Handa S; Horvath B; Ioannides D; Kasperkiewicz M; Kowalewski C; Lehman JS; Lipman RE; Mascaró JM; Meijer JM; Mimouni D; Schultz B; Skiljevic D; Strong B; Tomayko M; Vestergaard C; Wozniak K; Yayli S; Joly P; Werth VP, 2026, 'International development of Investigator Global Assessment scores for pemphigus', Journal of the European Academy of Dermatology and Venereology, 40, pp. e807 - e812, http://dx.doi.org/10.1111/jdv.70430

Yang A; Tan B; Murrell DF, 2026, 'Neutrophilic Dermatosis and Pyoderma Gangrenosum: A Not-So-Sweet Adverse Reaction to Pembrolizumab', Australasian Journal of Dermatology, 67, pp. 379 - 381, http://dx.doi.org/10.1111/ajd.70133

Hwang S; Stark M; Taylor SC; Rodrigues M; Alexis A; Murrell DF, 2026, 'Severity outcome measures in patients with skin of color: Gaps in current scoring systems and opportunities for improvement', Jaad Reviews, 9, pp. 73 - 84, http://dx.doi.org/10.1016/j.jdrv.2026.05.005

Pan JT; Daniel BS; Tan B; Lim BXH; Murrell DF; Watson SL; Lim CHL, 2026, 'Highlighting Ophthalmic Adverse Effects Associated with Isotretinoin', Life, 16, pp. 1441, http://dx.doi.org/10.3390/life16091441

Silverberg JI; Rosmarin D; Bieber T; Chovatiya R; Gooderham M; Gkalpakiotis S; Reich A; Murrell DF; Skibinska J; Sadick N; Blajić I; Tsianakas A; Fernandez-Penas P; Kern JS; Montero-Vílchez T; Popov TA; Kurian A; Sauder MB; Laquer VT; Chaudhry S; Lee ZH; Hannaway M; Yu D; Liu Y; Fanton C; Lu H; Kotzin B; Tagliaferri M; Zalevsky J; Warren RB, 2026, 'Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study', Lancet London England, 408, pp. 833 - 846, http://dx.doi.org/10.1016/S0140-6736(26)01143-8

Walter S; Martin LK; Murrell DF, 2026, 'Gender balance at international medical congresses: The EADV congress example, 2015–2023', Journal of the European Academy of Dermatology and Venereology, 40, pp. e709 - e711, http://dx.doi.org/10.1111/jdv.70386

Tan B; Yang A; Murrell DF, 2026, 'Repurposing therapies in junctional epidermolysis bullosa: Oral ivermectin therapy associated with improved wound healing and reduced pruritus', Jaad Case Reports, 74, pp. 218 - 220, http://dx.doi.org/10.1016/j.jdcr.2026.06.019

Silverberg JI; Beck LA; Gooderham M; Murrell DF; Wiseman MC; Sørensen L; Jönsson PG; Stein-Gold L, 2026, 'Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial', British Journal of Dermatology, pp. ljag296, http://dx.doi.org/10.1093/bjd/ljag296

Pathak GN; Syed A; Pathak SS; Tan B; Murrell DF, 2026, 'Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort.', Clin Exp Dermatol, http://dx.doi.org/10.1093/ced/llag312

Nanda A; Tedbirt B; Bodemer C; Bolling MC; El Hachem M; Nikolić M; Benton E; Caproni M; De D; Didona D; Drenovska K; Goebeler M; Hertl M; Horváth B; Kasperkiewicz M; Kiritsi D; Larralde M; Marzano AV; Meijer J; Murrell DF; Powell J; Sprecher E; Chandran NS; Tomayko MM; Uzun S; van Beek N; Ott H; Patsatsi A; Torrelo A; Welfringer-Morin A; Schmidt E; Joly P, 2026, 'European S2k guidelines on management of autoimmune blistering diseases in children and adolescents', Journal of the European Academy of Dermatology and Venereology, 40, pp. 1137 - 1161, http://dx.doi.org/10.1111/jdv.70308

Syed A; Leung HFA; Tan B; Melbourne W; Murrell DF, 2026, 'Successful treatment of chemotherapy-induced linear bullous lichen planus with dupilumab', Jaad Case Reports, 73, pp. 177 - 181, http://dx.doi.org/10.1016/j.jdcr.2026.05.005

Syed A; Khan MT; Murrell DF, 2026, 'Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex', Australasian Journal of Dermatology, 67, pp. e255 - e256, http://dx.doi.org/10.1111/ajd.70086

Pathak GN; Tan B; Syed A; Murrell DF, 2026, 'Immunomodulators and Antineoplastics Are Reported in Drug-Associated Epidermolysis Bullosa Acquisita Flares: A Retrospective Analysis of 58 Reported Cases Utilizing Multiple International Pharmacovigilance Databases', International Journal of Dermatology, 65, pp. 1114 - 1116, http://dx.doi.org/10.1111/ijd.70218

Murrell DF; Yamagami J, 2026, 'The plot thickens in pemphigus: New therapeutic targets from state-of-the-art ex vivo assays', Journal of Investigative Dermatology, 146, pp. 876 - 878, http://dx.doi.org/10.1016/j.jid.2026.01.001

Heyworth A; Stark M; Murrell D, 2026, 'Bewertungssysteme für das Schleimhautpemphigoid – eine Literaturübersicht', Skin, pp. 32 - 33, http://dx.doi.org/10.61783/oegdv10905

Stark M; Rivero ADL; Murrell DF, 2026, 'Photoallergic drug eruption secondary to oral terbinafine prescribed for management of tinea incognita', Skin, pp. 20 - 21, http://dx.doi.org/10.61783/oegdv10803

Dulai AS; Murase EM; Avallone G; Ferrucci SM; Marzano AV; Ribero S; Ardern-Jones M; Ko E; Flohr C; Leshem YA; Deleuran M; Vestergaard C; Hijnen DJ; Bras J; Elman SA; Pruneddu S; Butler D; Chovatiya R; Girolomoni G; Golant AK; Kamsteeg M; Luna PC; Murrell DF; Stark M; Torres T; Yildrim EA; Aractingi S; Bangert C; Batchelor R; Chen KY; Irvine AD; Lullo JJ; Martin LK; Maul JT; Pérez B; Rosmarin D; Sansom JE; Schultz B; Shipman A; Silverberg NB; Szalai Z; Fodor A; Tanaka AA; Viola K; Sivamani RK; Murase JE, 2026, 'International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes', Journal of the American Academy of Dermatology, 94, pp. 936 - 940, http://dx.doi.org/10.1016/j.jaad.2025.10.123

Syed A; Sarsam S; Murrell DF, 2026, 'Dual control of chronic plaque psoriasis and pouchitis with tildrakizumab', Clinical and Experimental Dermatology, 51, pp. 313 - 314, http://dx.doi.org/10.1093/ced/llaf468

Tseng H; Frew JW; Murrell DF, 2026, 'Viral infections as triggers in autoimmune blistering diseases: A systematic review of associations and mechanisms', Jaad International, 24, pp. 132 - 133, http://dx.doi.org/10.1016/j.jdin.2025.09.007

Zambruno G; Samela T; Diociaiuti A; Salamon G; Strobl S; Pilo C; Abeni D; Linertová R; Murrell DF; Hachem MEL, 2026, 'A Cross-sectional Study on Quality of Life in EB: Validation of the Italian QOLEB and Assessment in Italian Patients', Acta Dermato Venereologica, 106, http://dx.doi.org/10.2340/actadv.v106.adv-2026-0543

Vu JT; Ahuja R; Murrell DF, 2026, 'Balancing feasibility and sensitivity: Investigator global assessments for lupus and dermatomyositis', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70612

Back to profile page